Raymond James Financial, a leading financial services company, has announced its robust first-quarter performance for Fiscal ...

James analyst Dane Leone maintained a Strong Buy rating and a $19.00 price target on Ocular Therapeutix (NASDAQ:OCUL), aligning with the broader analyst consensus. According to InvestingPro data, ...

James initiated coverage on Robinhood Markets (NASDAQ: HOOD) with a Market Perform rating, citing concerns over the ...